[
  {
    "ts": "2025-02-11T13:00:00+00:00",
    "headline": "Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors",
    "summary": "BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced the appointment of Elizabeth Mily to its Board of Directors as Independent Director. A highly respected healthcare and financial industry veteran with more than 30 years of experience, Mily brings extensive expertise in corporate strategy, business development and investment leadership to Amp",
    "url": "https://finance.yahoo.com/news/ampersand-biomedicines-appoints-elizabeth-mily-130000708.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "94966a45-97b2-3ad0-94b8-6ad873bcaf60",
      "content": {
        "id": "94966a45-97b2-3ad0-94b8-6ad873bcaf60",
        "contentType": "STORY",
        "title": "Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors",
        "description": "",
        "summary": "BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced the appointment of Elizabeth Mily to its Board of Directors as Independent Director. A highly respected healthcare and financial industry veteran with more than 30 years of experience, Mily brings extensive expertise in corporate strategy, business development and investment leadership to Amp",
        "pubDate": "2025-02-11T13:00:00Z",
        "displayTime": "2025-02-11T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/e75526c0417957c867f3b7948be8d590",
          "originalWidth": 2539,
          "originalHeight": 742,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qeqYxzcr3znb6OSN_q8CgQ--~B/aD03NDI7dz0yNTM5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/e75526c0417957c867f3b7948be8d590.cf.webp",
              "width": 2539,
              "height": 742,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nJI_KiK5NOzAaRp.Ujnu3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e75526c0417957c867f3b7948be8d590.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ampersand-biomedicines-appoints-elizabeth-mily-130000708.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ampersand-biomedicines-appoints-elizabeth-mily-130000708.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SOLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]